US FTC Sues Hims & Hers Over Health Data Sharing and Billing Practices
On July 29, 2026, the U.S. Federal Trade Commission, along with Los Angeles County and Utah, sued telehealth company Hims & Hers for allegedly sharing users’ sensitive health data with Meta and Snap without consent, charging for prescriptions before consultations, and making cancellations difficult. The company denies the claims, calling them baseless. Hims & Hers stock fell about 12% following the lawsuit, which could set precedents for telehealth privacy and consumer protection.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection
Cross-source coverage
Wire timeline
HIMS Stock in Focus as FTC Lawsuit Takes Aim at Hims & Hers Business Practices
On July 29, 2026, the Federal Trade Commission, along with Utah and Los Angeles County, filed a lawsuit against telehealth provider Hims & Hers (HIMS), alleging the company misled consumers about recurring subscriptions, obstructed cancellations, and illegally shared private patient health data with ad platforms like Meta and Snap. The news caused HIMS stock to tank, though it rebounded slightly on July 30, remaining about 32% below its recent high. The article analyzes the bearish implications for HIMS, including potential financial penalties, increased churn rates, and loss of consumer trust. It notes the stock has fallen below its 100-day moving average, indicating sustained bearish momentum. Despite a consensus 'Hold' rating and a mean price target of $30 (20% upside), the article warns of risks including an expected Q2 loss of $0.07 per share, tense legal battles with Novo Nordisk over GLP-1 drugs, and insider selling (11 sells vs. 1 buy in three months).
FTC Sues Hims & Hers Over Health Data Sharing and Billing Practices
The Federal Trade Commission (FTC), joined by Utah and Los Angeles County, filed a federal lawsuit against Hims & Hers Health on July 29, 2026, alleging the company shared consumers' sensitive health information with third-party advertising platforms Meta and Snap without consent. The FTC also claims Hims & Hers charged customers before they consulted with a medical provider and made subscription cancellations deliberately difficult. The lawsuit, filed in the Northern District of California, alleges violations of the FTC Act and the Restore Online Shoppers' Confidence Act, along with state consumer protection laws. Hims & Hers rejected the allegations, stating the lawsuit disregards evidence from a three-year investigation. The company's stock fell approximately 12% following the announcement. The case comes as Hims & Hers transitions its business model away from compounded weight loss drugs toward branded GLP-1 medications, having reported a net loss of $92.1 million in Q1 2026.
FTC Sues Hims & Hers Over Data Sharing and Deceptive Billing Practices
The Federal Trade Commission (FTC), joined by Utah and California, has filed a lawsuit against telehealth company Hims & Hers Health. The complaint alleges that Hims & Hers unlawfully shared users' sensitive health information with third-party advertising platforms, despite promising to protect patient privacy. Additionally, the FTC claims the company engaged in deceptive billing practices by charging patients for recurring subscription plans shortly after receiving intake forms, often before they had consulted with a healthcare provider. The lawsuit also accuses Hims & Hers of making it difficult for consumers to cancel their subscriptions. The case highlights growing regulatory scrutiny of digital health companies regarding data privacy and consumer protection.
Show 4 older updatesHide older updates
Hims and Hers shares fall 10% as FTC sues company over data, billing practices
Shares of telehealth company Hims & Hers Health fell sharply after the Federal Trade Commission (FTC), joined by Los Angeles County and Utah, sued the company. The FTC alleges Hims & Hers shared sensitive user health information with advertising platforms including Meta and Snap without proper consent, charged customers for prescriptions before provider consultations, and made subscription cancellations difficult. The company denied wrongdoing, calling the lawsuit unsupported after a nearly three-year FTC investigation. Hims & Hers disclosed a $15 million probable-loss accrual related to the matter in May. The lawsuit escalates a dispute that began with an FTC investigation in October 2023, which also involved scrutiny of the company's Super Bowl ad and compounded weight loss drugs.
FTC Sues Hims & Hers Over Unauthorized Charges and Health Data Sharing
The Federal Trade Commission, along with California and Utah, has sued telehealth platform Hims & Hers Health for allegedly charging patients for prescription subscriptions without their consent and sharing sensitive health data with tech companies like Meta and Snap. The complaint, filed in the Northern District of California, accuses the company of violating the FTC Act and the Restore Online Shoppers' Confidence Act by enrolling consumers in recurring subscriptions without giving them a chance to review or decline treatment, making cancellations deliberately difficult, and processing refill charges earlier than advertised. Hims & Hers called the claims 'baseless' and vowed to fight them. The company's stock fell over 11% following the announcement. The lawsuit could set significant precedents for telehealth consumer protection, billing practices, and data privacy.
US FTC sues Hims & Hers for sending user health info to Meta, Snap
The U.S. Federal Trade Commission (FTC), along with Los Angeles County and Utah, filed a lawsuit against telehealth platform Hims & Hers on July 29, 2026. The FTC alleges that Hims & Hers shared users' sensitive health information with online advertising companies including Meta Platforms and Snap, despite promising privacy. The lawsuit also claims the company engaged in deceptive billing practices, charging users for prescriptions before they consulted with healthcare providers, and making it difficult to cancel subscriptions. Hims & Hers stock dropped around 12% following the news. The company called the claims baseless, stating the enforcement is an effort to generate headlines. Hims & Hers is a major player in the telehealth market, offering services for weight loss, erectile dysfunction, hair loss, and mental health.
US FTC Sues Hims & Hers for Sharing User Health Data with Meta and Snap
The U.S. Federal Trade Commission (FTC), along with Los Angeles County and Utah, filed a lawsuit against telehealth platform Hims & Hers on July 29, 2026. The lawsuit alleges that Hims & Hers shared users' sensitive health information with online advertising companies, including Meta Platforms and Snap, despite promising privacy. The FTC also accused the company of deceptive billing practices, charging users for prescriptions before they had a consultation with a healthcare provider, and making it difficult to cancel subscriptions. Hims & Hers, a major player in the weight loss drug market and provider of telehealth services for erectile dysfunction, hair loss, and mental health, saw its stock drop approximately 12% following the news. The company denied the allegations, calling them baseless and an effort to generate headlines.